Showing posts with label costing. Show all posts
Showing posts with label costing. Show all posts

Tuesday, 28 October 2014

Improving the accuracy of operation coding in surgical discharge summaries

" We suggest that specifically designed coding tables be introduced across each surgical department to ensure accurate OPCS codes are used to produce better quality surgical discharge summaries and to ensure correct reimbursement to the Trust."

Improving the accuracy of operation coding in surgical discharge summaries
E Martinou, G Shouls, N Betambeau
BMJ Quality Improvement Reports 2014;3

Read more here.

Monday, 6 October 2014

Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers

"Self-monitoring through use of CoaguChek XS or InRatio2 PT/INR coagulometers has the potential to be cost-saving for CCGs as the increased frequency of INR monitoring may improve health outcomes by enabling the dose of therapy to be adjusted more accurately, thereby avoiding adverse events that can result from an inappropriate dose of long-term vitamin K antagonist therapy, such as stroke and major haemorrhage."

Atrial fibrillation and heart valve disease: self‑monitoring coagulation status using point‑of‑care coagulometers: costing statement
NICE
September 2014

Read more here.

Assessing motility of the gastrointestinal tract using a wireless capsule: audit tool

"NICE has recommended that assessing motility of the gastrointestinal tract using a wireless capsule should only be used with special arrangements for audit. This means that clinicians carrying out the procedure should audit and review the outcomes of all patients. Audit data should be reviewed at appropriate intervals and practice should be changed if the results suggest the need to do so."

Assessing motility of the gastrointestinal tract using a wireless capsule: clinical audit tool
NICE
September 2014

Access the tool here.

Monday, 15 September 2014

NICE Drug allergy: costing statement

"This costing statement considers the cost implications of implementing the recommendations made in Drug allergy: diagnosis and management of drug allergy in adults, children and young people (NICE clinical guideline 183). 1.2 A costing statement of resource effects has been produced for this guideline as variation in clinical practice across the country means users should consider and assess the impact locally."

Costing statement: Drug allergy: diagnosis and management of drug allergy in adults, children 
and young people. Implementing the NICE guideline on Drug allergy in adults, children and young people (CG183)
NICE
September 2014

Read more here.

Friday, 13 June 2014

Improving the quality of costing in the NHS

"there were only a limited number of organisations where cost information was used routinely outside of the finance department, and even less where it was used by clinicians to improve their own efficiency and the care that they delivered."

Improving the quality of costing in the NHS: Payment by Results data assurance framework
CAPITA
June 2014

Read more here.

Tuesday, 2 October 2012

Reviewing end of life care costing information to inform the QIPP End of Life Care Workstream

"There are potential savings that could be released by shifting care from the acute to the community setting if such is the patient’s wish and if the commensurate disinvestment in acute care systems can be achieved."

Reviewing end of life care costing information to inform the QIPP End of Life Care Workstream
National End of Life Care Programme
September 2012

Read more here.